Literature DB >> 19498032

APO866 activity in hematologic malignancies: a preclinical in vitro study.

Michele Cea, Gabriele Zoppoli, Santina Bruzzone, Floriana Fruscione, Eva Moran, Anna Garuti, Ilaria Rocco, Gabriella Cirmena, Salvatore Casciaro, Francesca Olcese, Ivana Pierri, Antonia Cagnetta, Fabio Ferrando, Riccardo Ghio, Marco Gobbi, Alberto Ballestrero, Franco Patrone, Alessio Nencioni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19498032     DOI： 10.1182/blood-2009-03-209213

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  8 in total

1.  The role of sirtuin 2 activation by nicotinamide phosphoribosyltransferase in the aberrant proliferation and survival of myeloid leukemia cells.

Authors:  Lan Dan; Olga Klimenkova; Maxim Klimiankou; Jan-Henning Klusman; Marry M van den Heuvel-Eibrink; Dirk Reinhardt; Karl Welte; Julia Skokowa
Journal:  Haematologica       Date:  2011-12-29       Impact factor: 9.941

2.  Intracellular NAD⁺ depletion enhances bortezomib-induced anti-myeloma activity.

Authors:  Antonia Cagnetta; Michele Cea; Teresa Calimeri; Chirag Acharya; Mariateresa Fulciniti; Yu-Tzu Tai; Teru Hideshima; Dharminder Chauhan; Mike Y Zhong; Franco Patrone; Alessio Nencioni; Marco Gobbi; Paul Richardson; Nikhil Munshi; Kenneth C Anderson
Journal:  Blood       Date:  2013-07-03       Impact factor: 22.113

3.  Overcoming temozolomide resistance in glioblastoma via dual inhibition of NAD+ biosynthesis and base excision repair.

Authors:  Eva M Goellner; Bradford Grimme; Ashley R Brown; Ying-Chih Lin; Xiao-Hong Wang; Kelsey F Sugrue; Leah Mitchell; Ram N Trivedi; Jiang-bo Tang; Robert W Sobol
Journal:  Cancer Res       Date:  2011-03-15       Impact factor: 12.701

4.  Interplay of adipokines and myokines in cancer pathophysiology: Emerging therapeutic implications.

Authors:  Maria Dalamaga
Journal:  World J Exp Med       Date:  2013-08-20

Review 5.  Physiological and pathophysiological roles of NAMPT and NAD metabolism.

Authors:  Antje Garten; Susanne Schuster; Melanie Penke; Theresa Gorski; Tommaso de Giorgis; Wieland Kiess
Journal:  Nat Rev Endocrinol       Date:  2015-07-28       Impact factor: 43.330

6.  Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells.

Authors:  Michele Cea; Debora Soncini; Floriana Fruscione; Lizzia Raffaghello; Anna Garuti; Laura Emionite; Eva Moran; Mirko Magnone; Gabriele Zoppoli; Daniele Reverberi; Irene Caffa; Annalisa Salis; Antonia Cagnetta; Micaela Bergamaschi; Salvatore Casciaro; Ivana Pierri; Gianluca Damonte; Filippo Ansaldi; Marco Gobbi; Vito Pistoia; Alberto Ballestrero; Franco Patrone; Santina Bruzzone; Alessio Nencioni
Journal:  PLoS One       Date:  2011-07-27       Impact factor: 3.240

7.  Effective targeting of NAMPT in patient-derived xenograft models of high-risk pediatric acute lymphoblastic leukemia.

Authors:  Klaartje Somers; Kathryn Evans; Richard B Lock; Michelle J Henderson; Leanna Cheung; Mawar Karsa; Tara Pritchard; Angelika Kosciolek; Angelika Bongers; Ali El-Ayoubi; Helen Forgham; Shiloh Middlemiss; Chelsea Mayoh; Luke Jones; Mahima Gupta; Ursula R Kees; Olga Chernova; Lioubov Korotchkina; Andrei V Gudkov; Stephen W Erickson; Beverly Teicher; Malcolm A Smith; Murray D Norris; Michelle Haber
Journal:  Leukemia       Date:  2019-12-17       Impact factor: 12.883

8.  Nicotinamide phosphoribosyl transferase (Nampt) is a target of microRNA-26b in colorectal cancer cells.

Authors:  Chenpeng Zhang; Jinlu Tong; Gang Huang
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.